Article

Low-dose SAHA enhances CD8+T cell-mediated antitumor immunity by upregulating MHC I expression in non-small cell lung cancers

2023-12-06

Abstract excerpt

<title>Abstract</title> <p>Non-small cell lung cancers (NSCLCs) is a highly aggressive lung cancer with poor responses to traditional therapies like surgery, radiotherapy, and chemotherapy. While immunotherapy has become an effective approach treating multiple types of cancer, solid tumors frequently exhibit immune escape through various mechanisms, including downregulation of MHC I expression. Whether upregulati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4e6cbe76-82ac-5f90-a923-bef076ec44b6
DOI: 10.21203/rs.3.rs-3585533/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Low-dose SAHA enhances CD8+T cell-mediated antitumor immunity by upregulating MHC I expression in non-small cell lung cancersDOI 10.21203/rs.3.rs-3585533/v1Read

Low-dose SAHA enhances CD8+ T cell-mediated antitumor immunity by boosting MHC I expression in non-small cell lung cancerSemantic proximity Read

Antitumor effects of histone deacetylase inhibitor suberoylanilide hydroxamic acid in epidermal growth factor receptor-mutant non-small-cell lung cancer lines in vitro and in vivo.Semantic proximity Read

Advances of HDAC inhibitors in tumor therapy: potential applications through immune modulationSemantic proximity Read

HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-Driven Small Cell Lung CancerSemantic proximity Read

A Novel Histone Deacetylase Inhibitor Exhibits Antitumor Activity via Apoptosis Induction, F-Actin Disruption and Gene Acetylation in Lung CancerSemantic proximity Read

HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseasesSemantic proximity Read

HDAC inhibitors in cancer biology: emerging mechanisms and clinical applicationsSemantic proximity Read

Differential Transcriptomic Modulation by Histone Deacetylase Inhibitor SAHA in LUAD and LUSCSemantic proximity Read

A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with ImmunotherapySemantic proximity Read

Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancerSemantic proximity Read

The immunomodulatory properties of the HDAC6 inhibitor ACY241 supports robust anti-tumor response in NSCLC when coupled with the chemotherapy drug OxaliplatinSemantic proximity Read

Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cellsSemantic proximity Read